A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants

Clinical trial NCT07454291 · RECRUITING

Trial details

NCT number: NCT07454291
Sponsor: Endeavor Biomedicines, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2026-04-28
Primary completion: 2026-10-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.